Serial Number 88799213
Registration 6290799
700

Registration Progress

Application Filed
Feb 15, 2020
Under Examination
Aug 4, 2020
Approved for Publication
Jun 9, 2020
Published for Opposition
Jun 9, 2020
Registered
Mar 9, 2021

Basic Information

Serial Number
88799213
Registration Number
6290799
Filing Date
February 15, 2020
Registration Date
March 9, 2021
Published for Opposition
June 9, 2020
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 9, 2021
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

Next Deadline
609 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-03-09)
Due Date
March 09, 2027
Grace Period Ends
September 09, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

19 events
Date Code Type Description
Mar 9, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 2, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 1, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 25, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jan 24, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 5, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 5, 2021 IUAF S USE AMENDMENT FILED
Aug 4, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 14, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 14, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 14, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 9, 2020 PUBO A PUBLISHED FOR OPPOSITION
Jun 9, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 7, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2020 DOCK D ASSIGNED TO EXAMINER
Feb 22, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 21, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 19, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of primary hyperoxaluria
First Use Anywhere: Dec 17, 2020
First Use in Commerce: Dec 17, 2020

Additional Information

Design Mark
The mark consists of a design of three hexagonal shapes in different sizes, the smaller two of which are adjacent to each other, and the largest of which is shown in different shading surrounding the smallest hexagon and partly overlapping the mid-sized hexagon.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005